YVETTE FREEMAN: Open Payments
NPI 1821864208 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 39 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,066 · 2025 $817
Food & beverage: $817
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $125 |
| Otsuka America Pharmaceutical, Inc. | 4 | $109 |
| Fresenius USA Marketing, Inc. | 4 | $85 |
| Calliditas Therapeutics US Inc. | 3 | $84 |
| Alexion Pharmaceuticals, Inc. | 4 | $83 |
| Vifor Pharma, Inc. | 3 | $76 |
| Travere Therapeutics, Inc. | 4 | $74 |
| Amgen Inc. | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
Products named: FARXIGA, JYNARQUE, VELPHORO, TARPEYO, ULTOMIRIS, Veltassa, KRYSTEXXA, JARDIANCE.
Industry payments across NC — which companies pay providers there.
